InvestorsHub Logo
Followers 0
Posts 4
Boards Moderated 0
Alias Born 12/29/2017

Re: None

Sunday, 04/01/2018 11:30:21 AM

Sunday, April 01, 2018 11:30:21 AM

Post# of 330
If you think about it, bayer, which sells Aleve, is well over $90 in the stock market, if this new drug can can get great marketing after all of it's trials, it sounds better than aleve. With this being just a small company without much else behind it this stock can still be up to $5-10 within the next 10 years.